XOMA Royalty Corp. (XOMA)
29.38
+2.24
(+8.25%)
USD |
NASDAQ |
Jan 14, 16:00
28.90
-0.48
(-1.63%)
After-Hours: 20:00
XOMA Royalty EPS Diluted (Quarterly): 0.6991 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 0.051 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Rezolute, Inc. | -0.1755 |
| Vistagen Therapeutics, Inc. | -0.5432 |
| Zevra Therapeutics, Inc. | -0.0097 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 10.35M |
| Revenue (Quarterly) | 9.351M |
| Total Expenses (Quarterly) | -0.998M |
| Enterprise Value | 396.06M |
| Gross Profit Margin (Quarterly) | 90.59% |
| Earnings Yield | 2.54% |
| Normalized Earnings Yield | -2.164 |